West Pharmaceutical Services (NYSE:WST) vs. Medline (NASDAQ:MDLN) Financial Survey

by · The Markets Daily

Medline (NASDAQ:MDLN – Get Free Report) and West Pharmaceutical Services (NYSE:WST – Get Free Report) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Insider & Institutional Ownership

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.8% of Medline shares are held by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Medline and West Pharmaceutical Services’ net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medline1.84%8.21%4.03%
West Pharmaceutical Services18.81%21.78%15.99%

Analyst Ratings

This is a summary of recent ratings for Medline and West Pharmaceutical Services, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medline242302.72
West Pharmaceutical Services011302.93

Medline currently has a consensus target price of $46.08, indicating a potential upside of 20.59%. West Pharmaceutical Services has a consensus target price of $424.67, indicating a potential upside of 1.62%. Given Medline’s higher probable upside, research analysts plainly believe Medline is more favorable than West Pharmaceutical Services.

Earnings & Valuation

This table compares Medline and West Pharmaceutical Services”s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medline$30.68 billion1.64$1.16 billion$0.4486.84
West Pharmaceutical Services$3.07 billion9.47$493.70 million$8.9146.90

Medline has higher revenue and earnings than West Pharmaceutical Services. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Summary

West Pharmaceutical Services beats Medline on 7 of the 13 factors compared between the two stocks.

About Medline

(Get Free Report)

Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations. The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations. Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally.

About West Pharmaceutical Services

(Get Free Report)

West Pharmaceutical Services designs and manufactures packaging components and delivery systems used by the pharmaceutical, biotechnology, and medical device industries. Its products help contain and administer injectable medicines and include elastomeric components, such as stoppers and seals, as well as syringe components and other packaging and delivery solutions. The company also provides contract manufacturing services for medical devices and pharmaceutical delivery systems. Its customers include companies developing and producing branded, generic, and biologic medicines.